GL1X · GenesisL1 explorer

MolNFT v1 · #40999 · protein + DNA + RNA

Cpd lesion containing RNA polymerase II elongation complex C

2JA7 · 5'-D(*TP*AP*AP*GP*TP*AP*CP*TP*TP*GP *AP*GP*CP*T)-3': “Cpd lesion containing RNA polymerase II elongation complex C”. X-ray diffraction, 2 ligands (ZN, MG), 20 pockets (best druggability 0.88). MolNFT v1 #40999 on GenesisL1: 3D…

PDB
2JA7
Type
protein + DNA + RNA
Length
7,926 residues
Chains
30
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5'-D(*TP*AP*AP*GP*TP*AP*CP*TP*TP*GP *AP*GP*CP*T)-3'; 5'-D(*AP*GP*CP*TP*CP*AP*AP*GP*TP*AP…
EC
2.7.7.6
UniProt
P04050, P08518, P16370, P20433, P20434, P20435, P34087, P20436, P27999, P22139, P38902, P40422
Ligands
ZN, MG
Pockets
20 · best druggability 0.88

Structure

x-ray diffraction · 15 distinct chains · 30% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
1, 45'-D(*TP*AP*AP*GP*TP*AP*CP*TP*TP*GP *AP*GP*CP*T)-3'dna7——
2, 55'-D(*AP*GP*CP*TP*CP*AP*AP*GP*TP*AP *CP*TP*TP*TP*TTP*CP*CP*BRUP*GP*GP*TP*CP*AP*TP*T)-3'dna18——
3, 65'-R(*UP*UP*CP*GP*AP*CP*CP*AP*GP*GP*AP)-3'rna10——
A, MDNA-directed RNA polymerase II largest subunit (EC 2.7.7.6)protein142138% helix, 15% strandP04050
B, NDNA-directed RNA polymerase II 140 kda polypeptide (EC 2.7.7.6)protein111528% helix, 20% strandP08518
C, ODNA-directed RNA polymerase II 45KDA polypeptide (EC 2.7.7.6)protein26725% helix, 19% strandP16370
D, PDNA-directed RNA polymerase II 32KDA polypeptide (EC 2.7.7.6)protein17746% helix, 6% strandP20433
E, QDNA-directed RNA polymerases I, II, and III 27 kda polypeptide (EC 2.7.7.6)protein21434% helix, 21% strandP20434
F, RDNA-directed RNA polymerases I, II, and III 23 kda polypeptide (EC 2.7.7.6)protein8728% helix, 16% strandP20435
G, SDNA-directed RNA polymerase II 19KDA polypeptide (EC 2.7.7.6)protein17110% helix, 47% strandP34087
H, TDNA-directed RNA polymerases I, II, and III 14.5 kda polypeptide (EC 2.7.7.6)protein1350% helix, 43% strandP20436
I, UDNA-directed RNA polymerase II subunit 9 (EC 2.7.7.6)protein1160% helix, 22% strandP27999
J, VDNA-directed RNA polymerases I/II/III subunit 10 (EC 2.7.7.6)protein6548% helix, 2% strandP22139
K, WDNA-directed RNA polymerase II 13.6 kda polypeptide (EC 2.7.7.6)protein11437% helix, 23% strandP38902
L, XDNA-directed RNA polymerases I, II, and III 7.7 kda polypeptide (EC 2.7.7.6)protein460% helix, 4% strandP40422

Ligands and binding sites

  • ZN · Zinc ion · metal · 16 copies · chains A, B, C, I, J, L, M, N, O, U, V, X
  • MG · Magnesium ion · metal · 2 copies · chains 3, A, 6, M

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111740.880.90152empty
29320.880.90104empty
37760.870.9193empty
410170.860.87102empty
510500.840.85106empty

Interfaces

81 interfaces between chains.

  • A–B · 9799 Ų buried · 133 hydrogen bonds · protein-protein
  • M–N · 9797 Ų buried · 129 hydrogen bonds · protein-protein
  • P–S · 2307 Ų buried · 26 hydrogen bonds · protein-protein
  • D–G · 2305 Ų buried · 22 hydrogen bonds · protein-protein
  • M–Q · 2252 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 disulfide, 4 modified (disulfide, nucleotide modification).

Compared structures

  • 2JA7 · CPD lesion containing RNA Polymerase II elongation complex C · the same entry in another collection · chain 1 against 1, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.